HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Enhanced host resistance to transplantable murine lymphosarcoma in Swiss mice by combined immunostimulation with BCG and polyinosinic-polycytidylic acid.

Abstract
Combined immunostimulation with BCG and double-stranded polyinosinic-polycytidylic acid (poly I . poly C) was more effective than single-modality immunostimulation in suppressing tumor growth in inbred Swiss mice. BCG sensitization followed by administration of poly I . poly C on the day of tumor cell injection significantly prolonged the survival period against parental lymphosarcoma (LS) and its ascites variant (LS-A). BCG and poly I . poly C given together on the day of tumor cell injection suppressed only LS-A and not LS. BCG or poly I . poly C given alone did not result in tumor cures. Silica injection given 2 days before poly I . poly C injection completely abrogated the antitumor effect of sequential treatment with BCG and poly I . poly C. Silica treatment given on and beyond the day of poly I . poly C injection did not abrogate the antitumor effect. This observation indicated that intact macrophage effector function was essential at the time of tumor cell inoculation to obtain an effective antitumor action.
AuthorsT B Poduval, M Seshadri, K Sundaram
JournalJournal of the National Cancer Institute (J Natl Cancer Inst) Vol. 72 Issue 1 Pg. 139-43 (Jan 1984) ISSN: 0027-8874 [Print] United States
PMID6582293 (Publication Type: Journal Article)
Chemical References
  • Adjuvants, Immunologic
  • BCG Vaccine
  • Poly I-C
Topics
  • Adjuvants, Immunologic (administration & dosage)
  • Animals
  • BCG Vaccine (administration & dosage)
  • Immunotherapy
  • Lymphoma, Non-Hodgkin (immunology, therapy)
  • Male
  • Mice
  • Mice, Inbred Strains
  • Neoplasm Transplantation
  • Poly I-C (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: